JPMorgan Chase & Co’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03K | Sell |
|
|||||
|
2025
Q1 | $1.86K | Sell |
|
|||||
|
2024
Q4 | $3K | Buy |
|
|||||
|
2024
Q3 | $3.05K | Buy |
|
|||||
|
2024
Q2 | $328 | Sell |
|
|||||
|
2024
Q1 | $27.1K | Buy |
|
|||||
|
2023
Q4 | $640 | Sell |
|
|||||
|
2023
Q3 | $1.9K | Sell |
|
|||||
|
2023
Q2 | $6.26K | Buy |
|
|||||
|
2023
Q1 | $0 | Sell |
|
|||||
|
2022
Q4 | $0 | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $6K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $3K | Buy |
|